Definitive Contract HDTRA110C0046

This federal contract award, valued at $5,379,526.00, was issued by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The award is for a base period and does not have a set-aside designation. DSTL has an Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $146.3 million over seven years,...

This is a $3,947,011.00 cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The contract is for a research and development effort focused on using virus-like particles as a novel platform for delivering protective antigens against Burkholderia bacteria. The contract does not have a set-aside designation. DSTL is a...

This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract, valued at $4,226,739.50, supports the "BASE PERIOD - AD92" requirement and has an ultimate completion date of June 26, 2021. The contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract...

This is a $1,189,718.74 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as D S T L (Defence Science and Technology Laboratory), a United Kingdom government entity. The contract is for research and development of pharmacological and biologic interventions to reduce inflammation and seizures caused by viral encephalitis. This award is not associated with a set-aside program. The original solicitation was a...

This is a $7,994,572.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract is for the generation of a novel antibody-antibiotic conjugate as a combination therapy platform to treat melioidosis or plague. This contract is not set aside. DSTL has secured multiple high-value federal contracts from DTRA...

This is a federal contract award to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The $4,636,158.00 cost-plus-fixed-fee contract was awarded by the Defense Threat Reduction Agency (DTRA) with a period of performance ending on September 30, 2022. The contract has no set-aside designation. DSTL is an experienced provider of advanced research and development services to U.S. federal agencies, with a focus...

This is a federal contract award to the Ministry of Defence (doing business as DSTL), a government entity in the United Kingdom, by the Defense Threat Reduction Agency (DTRA). The $824,565 cost-plus-fixed-fee contract supports chemical agent system testing. The work, which is not set aside, involves research and development services focused on countering chemical, biological, radiological, and nuclear threats. This includes developing medical countermeasures, diagnostic tools, conducting...

This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Sanofi Pasteur Vaxdesign Corp, a for-profit foreign-owned organization. The contract is a Cost Plus Fixed Fee Definitive Contract with a ceiling value of $10,779,939.95 and an ultimate completion date of March 24, 2018. The contract was awarded on March 21, 2013 and does not have a set-aside designation. The contract is for the BASE YEAR, indicating it may be part of a larger contract...

The Defense Threat Reduction Agency awarded a $4,387,571.00 Cost Plus Fixed Fee contract to the Ministry of Defence, doing business as D S T L, a U.K. government entity located in Great Britain. The contract is for the development of chemical and biological decision support tools, with a completion date of July 21, 2022. The work supports U.S. defense and homeland security efforts to counter emerging biological and chemical threats, and may involve activities such as research on medical...

This is a $2,758,080.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (doing business as D S T L), a United Kingdom government entity. The contract is for the project "HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)" and has a March 30, 2023 completion date. The contract was awarded on December 10, 2018 and was not set aside for any special designation. D S T L, as a foreign government...